AI grant targets deadliest form of ovarian cancer
University of Michigan researcher receives a multimillion-dollar grant to use AI to better predict survival and treatment outcomes for the most common and deadly form of ovarian cancer.
Epidemiology Results
Cumulative lead exposure linked to increased Alzheimer's and dementia risk, U-M study finds
Researchers show bone lead from past environmental exposures increases dementia risk in older US adults
New U-M research reveals older adults with high cumulative lead exposure face nearly triple the Alzheimer's risk. The study suggests reducing population lead levels could prevent thousands of dementia cases annually.
Study pairs key air pollutants with home addresses to track progression of lost mobility through disability
Research traces 10 years of exposure to deteriorating mobility in older Americans
Long-term exposure to higher residential air pollution levels is associated with faster declines in physical function and reduced chances of recovery, according to a new U-M study. The research suggests cleaner air may allow people to stay stronger and more independent as they age.
On the Heights: January 2026
January highlights include groundbreaking research on structural racism and environmental health, new Impact Institute and sustainability funding awards, and faculty expertise featured in national media coverage and global health initiatives.
Building a better vaccine: Study IDs expanded, role of flu antibodies in preventing transmission
Findings suggest future vaccines use natural antibodies to target both infection and spread
Today’s influenza vaccines primarily prevent infection in individuals, but new research led by the University of Michigan and the Institut Pasteur suggests that incorporating antibodies generated after infection could lead to more powerful vaccines by also reducing person-to-person transmission.
Adults face lasting effects months after RSV hospitalization
Q&A with Aleda Leis
New research reveals RSV hospitalization causes lasting effects in adults of all ages—including breathlessness and reduced daily functioning months later. Learn why younger adults are more vulnerable than expected and how outcomes compare to COVID-19.